| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in HTFL over the last quarter tilts toward selling: insiders offloaded a net 304,105 shares worth roughly $14.2M. In the past 30 days, 0 insiders bought and 1 sold. The bias lately has been to the sell side.
On the other side, 1 insider reduced a position over the period. HTFL sits in the Health Care Technology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.50M | $248.16M | - | |
| CEO | 283.0K | $14.03M | -38,900 | |
| Dir | 226.8K | $1.89M | - | |
| Dir | 188.2K | $3.58M | - | |
| CFO | 155.2K | $7.88M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | Farquhar John C.M. | Chief Executive Officer | Sell | 15,560 | $39.06 | $607,773.60 | -3.6% | - | - | |
| Aug 10, 2026 | Farquhar John C.M. | Chief Executive Officer | Sell | 22,562 | $28.31 | $638,730.22 | -4.9% | - | - | |
| Jul 15, 2026 | Rogers Campbell | Chief Medical Officer | Sale+OE | 9,219 | $25.72 | $237,112.68 | -9.4% | +84.7% | - | |
| Jul 10, 2026 | Farquhar John C.M. | Chief Executive Officer | Sell | 22,562 | $27.75 | $626,095.50 | -4.9% | +78.3% | - | |
| Jun 24, 2026 | Farquhar John C.M. | Chief Executive Officer | Sell | 38,900 | $35.00 | $1,361,500.00 | -7.8% | +43.7% | - | |
| Jun 10, 2026 | Farquhar John C.M. | Chief Executive Officer | Sell | 22,562 | $28.50 | $643,017.00 | -4.3% | +62.2% | - | |
| May 18, 2026 | Rogers Campbell | Chief Medical Officer | Sale+OE | 9,219 | $28.34 | $261,266.46 | -10.5% | +63.5% | - | |
| May 11, 2026 | Farquhar John C.M. | Chief Executive Officer | Sell | 22,562 | $29.12 | $657,005.44 | -4.2% | -0.1% | - | |
| Apr 30, 2026 | Bain Capital Life Sciences Investors, LLC48 | 10% Owner | Sell | 2,000,000 | $29.45 | $58,898,336.45 | -19.1% | -15.9% | - | |
| Apr 10, 2026 | Farquhar John C.M. | Chief Executive Officer | Sell | 22,562 | $26.72 | $602,856.64 | -3.9% | +2.9% | - |